世卫组织今年早些时候发布的一个报告表明，耐多药结核病发病率已达到记录新高。
Earlier this year, WHO issued a report showing that multi-drug resistant TB has reached the highest levels ever recorded.
感染艾滋病毒者罹患耐多药结核病的风险较大，其死亡率大幅上升，存活时间大大减少。
People living with HIV have a higher risk of MDR-TB, with a greatly increased mortality and a greatly reduced survival time.
这两个地区同爱沙尼亚和拉脱维亚两个国家都扭转了耐多药结核病发病率升高的局面，最终实现了下降。
These regions join two countries, Estonia and Latvia, which have reversed rising high rates of MDR-TB, ultimately achieving a decline.
以前的报告中发现，艾滋病毒携带者同时感染耐多药结核病和广泛耐药结核病的病例中死亡率很高。
Previous reports found high levels of mortality among people living with HIV and infected with MDR-TB and XDR-TB.
结核病规划在减少耐多药结核病发病率方面面临着巨大挑战。
Tuberculosis programmes face tremendous challenges in reducing MDR-TB rates.
结核病规划在减少耐多药结核病发病率方面面临着巨大挑战。
Tuberculosis programmes face tremendous challenges in reducing MDR-TB rates.
应用推荐